Astera Labs, Inc. (ALAB) FY2026 Q2 Statement of Cash Flows

Statement of Cash Flows

2026-04-01 to 2026-06-30

Swipe to see the full flow
Astera Labs, Inc. cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $87,678,000.00Net income → Operating adjustments reconciliation: $65,410,000.00Stock-based compensation → Operating adjustments reconciliation: $63,992,000.00Accrued expenses and other liabilities → Operating adjustments reconciliation: $20,484,000.00Warrants contra revenue → Operating adjustments reconciliation: $10,216,000.00Depreciation and amortization → Operating adjustments reconciliation: $3,929,000.00Accounts payable → Operating adjustments reconciliation: $3,510,000.00Non-cash operating lease expense → Operating adjustments reconciliation: $1,541,000.00Operating adjustments reconciliation → Accounts receivable, net: $57,672,000.00Operating adjustments reconciliation → Prepaid expenses and other assets: $55,311,000.00Operating adjustments reconciliation → Inventory: $53,473,000.00Operating adjustments reconciliation → Other, net: $1,648,000.00Operating adjustments reconciliation → Accretion of discounts on marketable securities: $978,000.00Proceeds from employee stock purchase plan → financing reconciliation: $6,294,000.00Proceeds from exercises of stock options → financing reconciliation: $754,000.00financing reconciliation → Net cash from financing activities: $7,048,000.00Net cash used in investing activities → investing reconciliation: $131,560,000.00Sales and maturities of marketable securities → investing reconciliation: $96,177,000.00investing reconciliation → Purchases of marketable securities: $203,104,000.00investing reconciliation → Purchases of property and equipment: $20,468,000.00investing reconciliation → Payments for business combinations, net of cash acquired: $4,165,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $148,357,000.00Net cash from operating activities → Cash sources and uses: $87,678,000.00Net cash from financing activities → Cash sources and uses: $7,048,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $111,523,000.00Cash sources and uses → Net cash used in investing activities: $131,560,000.00Net income: $153,088,000.00Net income+$153.09 MStock-based compensation: $63,992,000.00Stock-based compensation+$63.99 MDepreciation and amortization: $3,929,000.00Depreciation & amortization+$3.93 MNon-cash operating lease expense: $1,541,000.00Operating lease amortization+$1.54 MWarrants contra revenue: $10,216,000.00Warrants contra revenue+$10.22 MAccretion of discounts on marketable securities: -$978,000.00Investment discount & premium−$978.00 KOther, net: -$1,648,000.00Other non-cash items−$1.65 MAccounts receivable, net: -$57,672,000.00Accounts receivable−$57.67 MInventory: -$53,473,000.00Inventories−$53.47 MPrepaid expenses and other assets: -$55,311,000.00Prepaid & other assets−$55.31 MAccounts payable: $3,510,000.00Accounts payable+$3.51 MAccrued expenses and other liabilities: $20,484,000.00Accrued & other liabilities+$20.48 MNet cash from operating activities: $87,678,000.00Operating cash+$87.68 MOperating adjustments reconciliation: $169,082,000.00Proceeds from employee stock purchase plan: $6,294,000.00Employee stock plan proceeds+$6.29 MProceeds from exercises of stock options: $754,000.00Stock option exercises+$754.00 KNet cash from financing activities: $7,048,000.00Financing cash+$7.05 Mfinancing reconciliation: $7,048,000.00Purchases of property and equipment: -$20,468,000.00PP&E purchases−$20.47 MPurchases of marketable securities: -$203,104,000.00AFS securities purchases−$203.10 MSales and maturities of marketable securities: $96,177,000.00Marketable securities proceeds+$96.18 MPayments for business combinations, net of cash acquired: -$4,165,000.00Acquisitions, net of cash−$4.17 MOther investing activities: $0.00Net cash used in investing activities: -$131,560,000.00. Cash required to fund net payments.Investing cash−$131.56 Minvesting reconciliation: $227,737,000.00Cash sources and uses: $243,083,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $148,357,000.00Beginning cash$148.36 MEnding cash: Cash, cash equivalents, and restricted cash: $111,523,000.00Ending cash$111.52 MCASH RECONCILIATIONOperatingflowsFinancingflowsInvestingflowsFree cash flow$67.21 MOperating cash − cash spent on PP&ECash flow / Net income0.57×Operating cash flow ÷ net incomeNet cash change−$36.83 MEnding cash − beginning cash
Chart details

Astera Labs, Inc. cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026

Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Mar 31, 2026
148,357,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
87,678,000 US dollars. Net cash provided.
Net income
153,088,000 US dollars
Stock-based compensation
63,992,000 US dollars
Depreciation and amortization
3,929,000 US dollars
Non-cash operating lease expense
1,541,000 US dollars
Warrants contra revenue
10,216,000 US dollars
Accretion of discounts on marketable securities
negative 978,000 US dollars
Other, net
negative 1,648,000 US dollars
Accounts receivable, net
negative 57,672,000 US dollars
Inventory
negative 53,473,000 US dollars
Prepaid expenses and other assets
negative 55,311,000 US dollars
Accounts payable
3,510,000 US dollars
Accrued expenses and other liabilities
20,484,000 US dollars
Investing activities
negative 131,560,000 US dollars. Net cash used.
Purchases of property and equipment
negative 20,468,000 US dollars
Purchases of marketable securities
negative 203,104,000 US dollars
Sales and maturities of marketable securities
96,177,000 US dollars
Payments for business combinations, net of cash acquired
negative 4,165,000 US dollars
Other investing activities
0 US dollars
Financing activities
7,048,000 US dollars. Net cash provided.
Proceeds from employee stock purchase plan
6,294,000 US dollars
Proceeds from exercises of stock options
754,000 US dollars
Operating adjustment reconciliation
169,082,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
7,048,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
227,737,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
0 US dollars
Ending cash on Jun 30, 2026
111,523,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
243,083,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
negative 36,834,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
0.57×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
87,678,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
20,468,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
67,210,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income exceeds operating cash. The diagram allocates $87.68M of net income directly to operating cash and $65.41M to the adjustment junction, where it combines with other additions to reconcile deductions. This is an accounting presentation, not a tracing of cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 87,678,000 US dollars minus 20,468,000 US dollars equals 67,210,000 US dollars.
Astera Labs, Inc. (ALAB) FY2026 Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!